← Back to Clinical Trials
Recruiting NCT07466147

NCT07466147 The Effect of Playful Physiotherapy Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07466147
Status Recruiting
Phase
Sponsor University of Tartu
Condition Attention Deficit Hyperactivity Disorder
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2026-05
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Playful physiotherapy programme

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2026-05 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this quasi-experimental study is to evaluate the changes in emotional, behavioral, and psychosocial functioning of children aged 7-12 following a playful physiotherapy intervention. The study focused on the potential effects of a play- and body-based intervention on children's daily functioning, based on parent-reported assessments The main question\[s\] it aims to answer \[is/are\]: Participants will be evaluated based on the Strengths and Difficulties Questionnaire and KIDSCREEN-27 before and after the playful physiotherapy intervention programme.

Eligibility Criteria

Inclusion Criteria: * Age 5-12 years; * Clinical diagnosis: ADHD, ASD, behavioral regulation difficulties, and/or social adaptation difficulties in group settings; * Participation in physiotherapy at ProVida Clinic or assessment by the clinic's rehabilitation team regarding suitability for participation; * Ability to participate in movement- and play-based activities in a group format; * Proficiency in Estonian; * No prior participation in a similar group. Exclusion Criteria: * Acute or chronic medical condition that prevents active participation; * Severe cognitive or sensory impairment that prevents understanding of activities or safe participation; * Situations in which the child's participation may disrupt group functioning or compromise safety.

Contact & Investigator

Central Contact

Hanna Kalajas-Tilga, PhD

✉ h9kala@gmail.com

📞 +37258361041

Frequently Asked Questions

Who can join the NCT07466147 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 12 Years, studying Attention Deficit Hyperactivity Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07466147 currently recruiting?

Yes, NCT07466147 is actively recruiting participants. Contact the research team at h9kala@gmail.com for enrollment information.

Where is the NCT07466147 trial being conducted?

This trial is being conducted at Tartu, Estonia.

Who is sponsoring the NCT07466147 clinical trial?

NCT07466147 is sponsored by University of Tartu. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology